A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
Clinical trial NCT06639347 · RECRUITING
Trial details
- NCT number
- NCT06639347
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2027-05-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.